A University of Chicago Consortium Phase II Trial of SB-715992 in Advanced Renal Cell Cancer

BACKGROUND: Advanced renal cell cancer (RCC) continues to have a poor overall prognosis despite new FDA-approved therapies. Although taxane-based therapies are generally ineffective in RCC, research into the role of the von Hippel-Lindau protein has shown an association with microtubule dynamics. Mi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lee, Richard T., Beekman, Kathleen E., Hussain, Maha, Davis, Nancy B., Clark, Joseph I., Thomas, Sachdev P., Nichols, Katherine F., Stadler, Walter M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2704464/
https://ncbi.nlm.nih.gov/pubmed/18501078
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky